✦ LIBER ✦

Deficient γ-interferon production in patients with systemic lupus erythematosus

✍ Scribed by George C. Tsokos; Dimitri T. Boumpas; Paula L. Smith; Julie Y. Djeu; James E. Balow; Alain H. Rook

Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 521 KB
Volume: 29
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.1780291005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon production in patients with s

Interferon production in patients with systemic lupus erythematosus

✍ Robert M. Friedman; Olivia Preble; Roberta Black; Sharon Harrell 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB 👁 2 views

Interferon production by lymphocytes fro

Interferon production by lymphocytes from patients with systemic lupus erythematosus

✍ Dr Donato Alarcon-Segovia; Juan Ruiz-Gomez; Eugenia Fishbei; Marfa Elena Bustama 📂 Article 📅 1974 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 2 views

Serum interferon levels in patients with

Serum interferon levels in patients with systemic lupus erythematosus

✍ Steven R. Ytterberg; Thomas J. Schnitzer 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 584 KB

Igm deficiency in systemic lupus erythem

Igm deficiency in systemic lupus erythematosus patients

✍ Ayşen Sivri; Zafer Hasçlik 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 2 views

Phenotype and function of natural killer

Phenotype and function of natural killer cells in systemic lupus erythematosus: Excess interferon-γ production in patients with active disease

✍ Baptiste Hervier; Vivien Beziat; Julien Haroche; Alexis Mathian; Pierre Lebon; P 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 338 KB 👁 2 views

Infection in patients with systemic lupu

Infection in patients with systemic lupus erythematosus

✍ H Daniel Perez; Richard I Andron; Ira M Goldstein 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 673 KB

## Abstract We have found subnormal amounts of chemotactic activity in zymosan‐treated sera from 13 of 29 patients with systemic lupus erythematosus (SLE). As an explanation for this abnormality, the presence of a uniquely specific, heat‐stable inhibitor of complement (C5)‐derived chemotactic activ